EGFL7 anticorps (C-Term)

N° du produit ABIN1589899

Cet anticorps Lapin Polyclonal détecte spécifiquement EGFL7 dans WB, IP et ICC. Il présente une réactivité avec des échantillons de Humain.

Aperçu rapide pour EGFL7 anticorps (C-Term) (ABIN1589899)

Antigène: EGFL7 (EGF-Like-Domain, Multiple 7 (EGFL7))

Reactivité: Humain

Hôte: Lapin

Clonalité: Polyclonal

Conjugué: Cet anticorp EGFL7 est non-conjugé

Application: Western Blotting (WB), Immunoprecipitation (IP), Immunocytochemistry (ICC)

Détail du produit anti-EGFL7 anticorps

Épitope: C-Term

Fonction: Rabbit Anti-Human VE-Statin/EGFL7 Polyclonal Antibody

Specificité: Recombinant human EGFL-7 C-Terminus

Attributs du produit: Chromosomal location: 9q34.3
Produced from sera of rabbits immunised with highly pure recombinant human VE-Statin/EGFL-7.

Purification: Anti-human VE-Statin/EGFL-7 was purified by Protein-A chromatography.

Immunogène: Recombinant human EGFL7 C-Terminus

Isotype: IgG

Information d'application

Indications d'application: Western Blot: Use 2-5 μg/mL

Restrictions: For Research Use only

Stockage

Format: Lyophilized

Reconstitution: Centrifuge vial prior to opening. Reconstitute in sterile water to a concentration of 0.1-1.0 mg/mL.

Buffer: PBS

Conseil sur la manipulation: Centrifuge vial prior to opening.

Stock: 4 °C,-20 °C

Stockage commentaire: The lyophilized antibody is stable for at least 2 years at -20°C. After sterile reconstitution the antibody is stable at 2-8°C for up to 6 months. Frozen aliquots are stable for at least 6 months when stored at -20°C. Addition of a carrier protein or 50% glycerol is recommended for frozen aliquots.

Date de péremption: 24 months

Détails sur EGFL7

Antigène: EGFL7 (EGF-Like-Domain, Multiple 7 (EGFL7))

Autre désignation: VE-Statin/EGFL7

Sujet:

Synonyms: EGFL7, NEU1, ZNEU1, VE-STATIN, RP11-251M1.2, NOTCH4-like protein, Vascular endothelial statin

Description: EGFL7 (VE-Statin) is an ~ 30 kDa secreted protein that contains an Emilin-like (EMI) domain (a multimerization motif), and two epidermal growth factor (EGF) domains, one of which binds calcium. Based on these domains, it has been hypothesized that EGFL7 may self-assemble like extracellular matrix (ECM) proteins and, thus, could incorporate into ECM. EGFL7 has been reported to stimulate cell adhesion as well as motility in a manner similar to ECM proteins. EGFL7 has been shown to be primarily expressed by developing ECs but also by primordial germ cells and some central nervous system neurons. Interestingly, EGFL7 expression markedly decreases in ECs in postnatal life, but can be strongly up-regulated after various tissue injuries that lead to increased angiogenic responses.

ID gène: 51164

NCBI Accession: NM_016215, NP_057299

UniProt: Q9UHF1